Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) – Stock analysts at Dougherty & Co issued their Q1 2018 earnings per share estimates for Allscripts Healthcare Solutions in a report released on Friday, according to Zacks Investment Research. Dougherty & Co analyst G. Mannheimer forecasts that the software maker will post earnings per share of $0.11 for the quarter. Dougherty & Co also issued estimates for Allscripts Healthcare Solutions’ FY2019 earnings at $0.75 EPS.
MDRX has been the topic of several other reports. Evercore ISI assumed coverage on Allscripts Healthcare Solutions in a research note on Thursday, January 18th. They issued an “outperform” rating and a $17.50 target price on the stock. TheStreet upgraded Allscripts Healthcare Solutions from a “c” rating to a “b-” rating in a research note on Thursday, February 15th. BidaskClub upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Cantor Fitzgerald restated a “buy” rating and issued a $17.00 target price on shares of Allscripts Healthcare Solutions in a research note on Sunday, January 28th. Finally, SunTrust Banks lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a research note on Tuesday, January 16th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $16.09.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last issued its earnings results on Thursday, February 15th. The software maker reported $0.18 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.18. The firm had revenue of $547.00 million for the quarter, compared to analyst estimates of $524.05 million. Allscripts Healthcare Solutions had a positive return on equity of 7.36% and a negative net margin of 10.88%. The business’s revenue was up 27.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.14 earnings per share.
A number of institutional investors have recently bought and sold shares of MDRX. Zeke Capital Advisors LLC purchased a new position in Allscripts Healthcare Solutions during the fourth quarter worth about $165,000. Avestar Capital LLC purchased a new position in Allscripts Healthcare Solutions during the fourth quarter worth about $173,000. Sheaff Brock Investment Advisors LLC purchased a new position in Allscripts Healthcare Solutions during the third quarter worth about $174,000. Quantitative Systematic Strategies LLC purchased a new position in Allscripts Healthcare Solutions during the fourth quarter worth about $182,000. Finally, Crossmark Global Holdings Inc. purchased a new position in Allscripts Healthcare Solutions during the third quarter worth about $187,000.
In related news, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $14.35, for a total transaction of $71,750.00. Following the completion of the transaction, the executive vice president now directly owns 191,607 shares in the company, valued at $2,749,560.45. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, President Richard J. Poulton sold 15,000 shares of the business’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $14.26, for a total value of $213,900.00. Following the transaction, the president now owns 1,351,773 shares of the company’s stock, valued at $19,276,282.98. The disclosure for this sale can be found here. Insiders own 0.91% of the company’s stock.
Allscripts Healthcare Solutions Company Profile
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.